Showing 81 - 100 of 149 results
Merit Access Terms and Conditions
By submitting a proposal for Merit Access to ANSTO’s Biosciences, Centre for Accelerator Science, Isotope Tracing, Nuclear Stewardship or the Vivarium capabilities, you are agreeing to the following Terms and Conditions. These Terms and Conditions apply to external merit researchers, scientific collaborators and partners unless there is a specific agreement in place between ANSTO and the home institution of the Principal Investigator.
Periodic table photo competition results
This science week ANSTO (August 10th - 18th) is running a classroom competition using the ANSTO Periodic Table and our new ANSTO XR app.
From the frontline: Dating the ancient past in tiny bites
Role at ANSTO
Dr Karina Meredith was appointed Director of the new Research and Technology Group for Environment effective 15 January 2024.
Role at ANSTO
Food and health
Consumers want to know that the foods they consume provide health benefits. Food materials science can monitor changes during digestion as well as assist in the development of low-fat products.
Advanced Diffraction & Scattering Beamlines (ADS-1 and ADS-2) UNDER CONSTRUCTION
The Advanced Diffraction and Scattering beamlines (ADS-1 and ADS-2) are two independently operating, experimentally flexible beamlines that will use high-energy X-ray diffraction and imaging to characterise the structures of new materials and minerals.
Successful Repatriation of Australia's Radioactive Waste
The Australian Government’s nuclear agency, ANSTO, together with NSW Police and multiple state and federal authorities, has completed an operation to repatriate radioactive waste from the UK.
User Meeting 2025 - Awards & Prizes
You are invited to submit to the various awards from ANSTO and the User Meeting 2025 organising committee.
Transport revolution on the horizon following discovery of ‘stainless magnesium’
X-rays reveal the key to the effectiveness of new Alzheimer’s drugs
Role at ANSTO
Remarkable clinical trial results shared internationally
A targeted radioactive infusion that is a game-changer in late-stage prostate cancer can also dramatically improve outcomes for patients in earlier stages of this disease, a Peter Mac-led study has shown.
Role at ANSTO
Technical Information - Far infrared
Technical information on the Far Infrared beamline at the Australian Synchrotron.
Role at ANSTO
New Joint Venture to manufacture GMP theranostic radiopharmaceuticals in Australia
Cyclotek and ANSTO have announced the launch of a Joint Venture (JV), to establish Australia’s first GMP (Good Manufacturing Practice) theranostics facility starting in Melbourne, Australia.